What is the NRX Pharmaceuticals Inc. stock price forecast?

NRX Pharmaceuticals Inc. is currently trading at $4.31. View real-time AI analysis on Alpha Lenz.

What is NRX Pharmaceuticals Inc. insider trading activity?

View the latest insider trading data for NRX Pharmaceuticals Inc. on Alpha Lenz.

What is NRX Pharmaceuticals Inc.'s P/E ratio?

View NRX Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.

NRX Pharmaceuticals Inc.

NASDAQ · NRXP

$4.31+1.09(+33.85%)Pre-market

Ask about NRX Pharmaceuticals Inc.'s future dividend policy...

Alpha Chat Insight

“NRX Pharmaceuticals Inc.'s ROE is 146.2%. Explore profitability and growth together.”

Ask for details →

Company Overview

NRX Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing innovative therapies for patients with potentially life-threatening conditions. With a focus on mental health, the company is at the forefront of research into therapeutic solutions for treatment-resistant depression, post-traumatic stress disorder, and bipolar depression, among other psychiatric conditions. NRX Pharmaceuticals operates in a highly targeted niche within the healthcare and pharmaceuticals sector, leveraging advanced scientific research to address unmet medical needs. By collaborating with academic and commercial partners, the company aims to accelerate the pace of drug development and bring novel treatments to market. The significance of NRX Pharmaceuticals in the financial market is underscored by its commitment to delivering transformative health solutions, ultimately improving patient outcomes and enhancing the quality of life for those it serves.

CEODr. Jonathan C. Javitt M.D., M.P.H.

Websitehttps://www.nrxpharma.com

SectorHealthcare

IndustryBiotechnology

Company Statistics

FY 2025

Profile

N/AMarket Cap

$1.23MRevenue

0.00Shares Out

0Employees

Margins

58.78%Gross

-2201.96%EBITDA

-1324.41%Operating

-2336.49%Pre-Tax

-2336.49%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-344.70%ROA

146.18%ROE

-336.62%ROIC

Financial Health

$7.80MCash & Cash Equivalents

$21.10MNet Debt

-181.30%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“NRX Pharmaceuticals Inc.'s ROE is 146.2%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

NRX Pharmaceuticals Inc. (ticker: NRXP) is a company listed on NASDAQ in the Healthcare sector (Biotechnology).

The current price is $4.31 with a P/E ratio of -x and P/B of -x.

ROE is 146.18% and operating margin is -1324.41%. Annual revenue is $1M.